Abbott (NYSE:ABT) is facing an FDA warning letter alleging quality system regulation violations related to FreeStyle Libre ...
On February 2, 2026, the U.S. Food and Drug Administration’s long-awaited harmonization of the medical device good manufacturing practice ...
The new Quality Management System Regulation (QMSR) that became effective on February 2, 2026, includes significant changes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results